Alogliptin (Nesina®) is a medication licensed for the treatment of type 2 diabetes. It is available by prescription only and comes as a tablet that is taken once a day.
In clinical studies, people had lower HbA1c (hemoglobin A1c) levels and fasting blood sugar when they took alogliptin. Because alogliptin can lower blood sugar levels, people may be able to lower their risk for developing problems related to high blood sugar, such as heart, nerve, eye, or kidney problems.
While most people tolerate this medicine well, it is not suitable for everyone. Before starting treatment with alogliptin, your healthcare provider will need information on your current medications (including nonprescription drugs) and any other medical conditions you have, such as liver or kidney problems.
(Click Alogliptin for information on how this diabetes drug works, side effects that may occur, and how to get the most out of each dose.)
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed February 20, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click